Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study
The levodopa-response in MSA-related dysphagia varies greatly. Some patients might improve markedly, necessitating individual assessments to tailor patient-specific therapies. Non-pharmacological measures should be investigated to address dysphagia in MSA. IACM again proved to be highly prevalent in MSA.
Authors
- Vera D. Jäger (ORCID: https://orcid.org/0000-0003-0449-133X)
- Luise Berger
- Dominic B. Rowe (ORCID: https://orcid.org/0000-0003-0912-2146)
- Georg Ebersbach (ORCID: https://orcid.org/0000-0003-3403-6987)
- Florin Gandor (ORCID: https://orcid.org/0000-0003-2874-9817)
- Adam P. Vogel (ORCID: https://orcid.org/0000-0002-3505-2631)
- Stefanie Schreiber (ORCID: https://orcid.org/0000-0003-4439-4374)
- Doreen Gruber (ORCID: https://orcid.org/0009-0009-4335-4718)
- Katja Schimming
- Katharina Demmin
- Paulina Thimm
Institutions
- University of Potsdam (DE)
- St Vincent's Hospital Sydney (AU)
- Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
- Macquarie University (AU)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1002/mdc3.70355
- Citations
- 2
- Primary Topic
- Dysphagia Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.24
Funders
- Macquarie University